Evidence map›Paper›PMID 34392465›Full record

ArticleJournal of bone and mineral metabolism2022

Baseline renal dysfunction determines mortality following parathyroidectomy in primary hyperparathyroidism: analysis of Indian PHPT registry.

Liza Das, Sanjay Kumar Bhadada, Sapara Mohin Arvindbhai, Divya Dahiya, Arunanshu Behera, Pinaki Dutta, Anil Bhansali, Ashwani Sood, Priyanka Singh, Mahesh Prakash and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of bone and mineral metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Liza DasDepartment of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.ORCID http://orcid.org/0000-0002-9701-9554
Sanjay Kumar BhadadaDepartment of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. bhadadask@gmail.com.ORCID http://orcid.org/0000-0002-0410-8778
Sapara Mohin ArvindbhaiDepartment of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Divya DahiyaDepartment of General Surgery, PGIMER, Chandigarh, India.
Arunanshu BeheraDepartment of General Surgery, PGIMER, Chandigarh, India.
Pinaki DuttaDepartment of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.ORCID http://orcid.org/0000-0001-5415-1611
Anil BhansaliDepartment of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.ORCID http://orcid.org/0000-0003-3621-4337
Ashwani SoodDepartment of Nuclear Medicine, PGIMER, Chandigarh, India.
Priyanka SinghDepartment of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Mahesh PrakashDepartment of Radiology, PGIMER, Chandigarh, India.
Poonam KumariDepartment of Endocrinology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Sudhaker D RaoDivision of Endocrinology, Diabetes, and Bone & Mineral Disorders, Bone & Mineral Research Laboratory, Henry Ford Hospital, Detroit, MI, USA.
Post Graduate Institute of Medical Education and Research · INHenry Ford Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPrimary hyperparathyroidism (PHPT) in India is mostly symptomatic with renal and skeletal complications. Evidence on mortality outcomes following parathyroidectomy from India, where the disease is predominantly symptomatic is limited. MATERIAL AND

methodsThis was a prospective study to evaluate mortality outcomes in the Indian PHPT registry over the past 25 years (n = 464). Pre- and postoperative parameters and mortality data were obtained from medical records and/or by verbal autopsy, a method validated by WHO for data collection in settings where several deaths are noninstitutional. Patients were divided into survivor (SG) and nonsurvivor groups (NSG) to ascertain differences in presentation and the effect of parathyroidectomy.

resultsThe overall mortality was 8.8% at a median follow-up of 8 years (IQR 1-13) after parathyroidectomy. Chronic kidney disease was the most common background cause of death (43.5%), followed by pancreatitis (28.2%). NSG had significantly more frequent renal dysfunction (91.9% vs 73.9%), anaemia (50 vs 16.6%) and pancreatitis (24.3 vs 6.4%). PTH (61.9 vs 38.3 pmol/l) and baseline creatinine (97.2 vs 70.7 µmol/l) were significantly higher and eGFR lower (66.7 vs 90.7 ml/min/1.73m

conclusionsNonsurvivors in PHPT had greater prevalence and more severe baseline renal dysfunction than survivors. Survival after parathyroidectomy was significantly associated with estimated glomerular filtration rate at baseline.

Indexed as

Hyperparathyroidism, PrimaryRenal Insufficiency, ChronicCalciumHumansParathyroidectomyParathyroid HormoneProspective StudiesRegistriesRetrospective StudiesCalciumParathyroid HormoneAnaemiaChronic kidney diseaseMortalityPancreatitisPrimary hyperparathyroidism

Identifiers

PMID34392465
OpenAlexW3195901874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.